Across CCLE and GDSC cell-line panels, response to Bleomycin is significantly associated with the protein-level pathway activity of multiple pathways, with OVARY cell lines showing a particularly strong set of associations.
The most reproducible Bleomycin response-associated pathways across cancer lineages are Negative regulation of proteasomal protein catabolic process, Negative regulation of neuron apoptotic process, and Negative regulation of proteasomal ubiquitin-dependent protein catabolic process, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Bleomycin response versus Negative regulation of proteasomal protein catabolic process protein-level pathway activity in OVARY (Pearson r = 0.30).